GB0716494D0 - HIV-2 antigenic peptides - Google Patents
HIV-2 antigenic peptidesInfo
- Publication number
- GB0716494D0 GB0716494D0 GBGB0716494.0A GB0716494A GB0716494D0 GB 0716494 D0 GB0716494 D0 GB 0716494D0 GB 0716494 A GB0716494 A GB 0716494A GB 0716494 D0 GB0716494 D0 GB 0716494D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- hiv
- antigenic peptides
- antigenic
- peptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 208000031886 HIV Infections Diseases 0.000 title 1
- 241000713340 Human immunodeficiency virus 2 Species 0.000 title 1
- 230000000890 antigenic effect Effects 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0716494.0A GB0716494D0 (en) | 2007-08-23 | 2007-08-23 | HIV-2 antigenic peptides |
PCT/GB2008/002831 WO2009024789A1 (en) | 2007-08-23 | 2008-08-21 | Hiv-2 antigenic peptides |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0716494.0A GB0716494D0 (en) | 2007-08-23 | 2007-08-23 | HIV-2 antigenic peptides |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0716494D0 true GB0716494D0 (en) | 2007-10-03 |
Family
ID=38599180
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0716494.0A Ceased GB0716494D0 (en) | 2007-08-23 | 2007-08-23 | HIV-2 antigenic peptides |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0716494D0 (en) |
WO (1) | WO2009024789A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012016713A1 (en) * | 2010-08-05 | 2012-02-09 | Ruprecht-Karls-Universität Heidelberg | Tumour targeting with polypeptides |
WO2015127201A1 (en) * | 2014-02-21 | 2015-08-27 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Hiv-2 nucleic acids and methods of detection |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6541609B2 (en) * | 1985-11-14 | 2003-04-01 | President And Fellows Of Harvard College | HIV-2 peptides |
US6322964B1 (en) * | 1987-01-16 | 2001-11-27 | Genetic Systems Corporation | Synthetic HIV-2 gag and env oligopeptides reactive with HIV-2 specific antibodies |
GB8910145D0 (en) * | 1989-05-03 | 1989-06-21 | Connaught Lab | Synthetic peptides for an hiv-1 vaccine |
US5883081A (en) * | 1995-07-26 | 1999-03-16 | The Regents Of The University Of California | Isolation of novel HIV-2 proviruses |
CN1233187A (en) * | 1996-08-09 | 1999-10-27 | 病毒技术公司 | HIVp-17 peptide fragment, compositions containing and methods for producing and using same |
MXPA02001349A (en) * | 1999-08-09 | 2002-07-22 | Tripep Ab | Protein polymerization inhibitors and methods of use. |
-
2007
- 2007-08-23 GB GBGB0716494.0A patent/GB0716494D0/en not_active Ceased
-
2008
- 2008-08-21 WO PCT/GB2008/002831 patent/WO2009024789A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2009024789A1 (en) | 2009-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL219048A (en) | Urcl10 derived peptide vaccines | |
HK1138853A1 (en) | Vaccine | |
IL201782A0 (en) | Vaccine | |
GB0717911D0 (en) | Vaccine | |
ZA201004303B (en) | Vaccine | |
GB0700135D0 (en) | Vaccine | |
ZA201001451B (en) | Immunomodulatory peptides | |
ZA201001029B (en) | Vaccines | |
GB0723712D0 (en) | Peptides | |
GB0920981D0 (en) | Peptides | |
IL199622A0 (en) | Foxp3 peptide vaccine | |
GB0710538D0 (en) | Vaccine | |
ZA201003851B (en) | Vaccine | |
GB0716494D0 (en) | HIV-2 antigenic peptides | |
GB0920987D0 (en) | Peptides | |
GB0817978D0 (en) | Peptides | |
GB0716224D0 (en) | Peptides for vaccine | |
GB0707626D0 (en) | Peptides | |
GB0705251D0 (en) | Peptides | |
GB0705115D0 (en) | Peptides | |
GB0701262D0 (en) | Vaccine | |
GB0712420D0 (en) | Vaccine | |
GB0724651D0 (en) | Vaccine | |
GB0721928D0 (en) | Vaccine | |
GB0713188D0 (en) | Vaccine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |